63O Letrozole and palbociclib versus third generation chemotherapy as neoadjuvant treatment in luminal breast cancer: Survival results of the UNICANCER-NeoPAL study
Titel:
63O Letrozole and palbociclib versus third generation chemotherapy as neoadjuvant treatment in luminal breast cancer: Survival results of the UNICANCER-NeoPAL study
Auteur:
Delaloge, S. Dureau, S. D'Hondt, V. Desmoulins, I. Heudel, P-E. Duhoux, F. Levy, C. Lerebours, F. Mouret-Reynier, M-A. Dalenc, F. Frenel, J-S. Jouannaud, C. Venat-Bouvet, L. Nguyen, S. Callens, C. Gentien, D. Manduzio, H. Vincent-Salomon, A. Lemonnier, J. Cottu, P.H.